A Ring-type Wearable Device for Atrial Fibrillation
CART Phase 2 Study: Diagnostic Performance of a Ring-type Wearable Device Using Deep Learning Analysis of Photoplethysmographic Signals for Detecting Atrial Fibrillation
1 other identifier
observational
200
1 country
1
Brief Summary
This study investigates diagnostic performance of a ring-type wearable device for detecting atrial fibrillation. This is a prospective cohort registry study began after the date of IRB approval and until 31th Dec. 2019. The eligible criteria are (1) those who admitted the institution for elective direct-current cardioversion of persistent atrial fibrillation, and (2) aged 19 years or more. The exclusion criteria are (1) those aged less than 19 years, (2) those who are not eligible to perform cardioversion by any reasons. This study aims to recruit 200 participants in total. The participants are required to record photoplethysmographic signals by the ring device in addition to routine procedures of direct-current cardioversion, hence, the study is at minimal risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 23, 2018
CompletedFirst Submitted
Initial submission to the registry
July 15, 2019
CompletedFirst Posted
Study publicly available on registry
July 17, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedMarch 18, 2020
March 1, 2020
2.6 years
July 15, 2019
March 16, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic performance
Diagnostic performance of a ring-type wearable device for detecting atrial fibrillation (parameters including sensitivity, specificity, positive predictive value, negative predictive value).
Baseline
Eligibility Criteria
The study consecutively recruits participants who admitted for elective direct-current cardioversion due to persistent atrial fibrillation.
You may qualify if:
- Those with persistent atrial fibrillation
- Those who admitted for elective direct-current cardioversion
- Those who aged 19 years or more
You may not qualify if:
- Those who aged less than 19 years
- Those who had other types of cardiac arrhythmias
- Those who are not eligible to perform electrical cardioversion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seoul National University Hospitallead
- Sky Labs Inc.collaborator
Study Sites (1)
Seoul National university Hostpital
Seoul, 03080, South Korea
Related Publications (1)
Kwon S, Hong J, Choi EK, Lee B, Baik C, Lee E, Jeong ER, Koo BK, Oh S, Yi Y. Detection of Atrial Fibrillation Using a Ring-Type Wearable Device (CardioTracker) and Deep Learning Analysis of Photoplethysmography Signals: Prospective Observational Proof-of-Concept Study. J Med Internet Res. 2020 May 21;22(5):e16443. doi: 10.2196/16443.
PMID: 32348254DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eue-Keun Choi, MD, PhD
Devision of Cardiology, Department of Internal Medicine, Seoul National University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 15, 2019
First Posted
July 17, 2019
Study Start
January 23, 2018
Primary Completion
August 30, 2020
Study Completion
December 31, 2020
Last Updated
March 18, 2020
Record last verified: 2020-03